Risk factors for survival after lung metastasectomy in colorectal cancer patients: Systematic review and meta-analysis

Future Oncology

Volumn 11, Issue 2s, 2015, Pages 31-33

  Gonzalez, Michel ^a   Gervaz, Pascal ^b  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b Clinique de La Colline   (Switzerland)

Author keywords

colorectal cancer; lung metastases; meta analysis; metastasectomy; systematic review

Indexed keywords

CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURVIVAL; COLORECTAL CANCER; HUMAN; LUNG METASTASECTOMY; LUNG RESECTION; META ANALYSIS; METASTASIS RESECTION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SURVIVAL RATE; SYSTEMATIC REVIEW; COLORECTAL TUMOR; LUNG NEOPLASMS; MORTALITY; PATHOLOGY; SECONDARY;

COLORECTAL NEOPLASMS; HUMANS; LUNG NEOPLASMS; METASTASECTOMY; RISK FACTORS; SURVIVAL RATE;

EID: 84922678877     PISSN: 14796694     EISSN: 17448301     Source Type: Journal    
DOI: 10.2217/fon.14.259     Document Type: Review

References (15)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J. Clin. 61(2), 69-90 (2011
2. Gonzalez M, Ris HB, Krueger T, Gervaz P. Colorectal cancer and thoracic surgeons: close encounters of the third kind. Expert Rev. Anticancer Ther. 12(4), 495-503 (2012
3. Cunningham D, Humblet Y, Siena S, et al. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N. Engl. J. Med. 351(4), 337-345 (2004
4. Giantonio BJ, Levy DE, O'dwyer P J, et al. A Phase II study of high-dose bevacizumab in combination with irinotecan, 5-fluorouracil, leucovorin, as initial therapy for advanced colorectal cancer: results from the Eastern Cooperative Oncology Group study E2200. Ann. Oncol. 17(9), 1399-1403 (2006
5. Treasure T. Pulmonary metastasectomy for colorectal cancer: weak evidence and no randomised trials. Eur. J. Cardiothorac. Surg. 33(2), 300-302 (2008
6. V N. NCCN Clinical Practice Guidelines in Oncology. www.nccn.org
7. Pfannschmidt J, Dienemann H, Hoffmann H. Surgical resection of pulmonary metastases from colorectal cancer: a systematic review of published series. Ann. Thorac. Surg. 84(1), 324-338 (2007
8. Pfannschmidt J, Hoffmann H, Dienemann H. Reported outcome factors for pulmonary resection in metastatic colorectal cancer. J. Thorac. Oncol. 5(6 Suppl. 2), S172-S178 (2010
9. Gonzalez M, Poncet A, Combescure C, Robert J, Ris HB, Gervaz P. Risk factors for survival after lung metastasectomy in colorectal cancer patients: a systematic review and meta-analysis. Ann. Surg. Oncol. 20(2), 572-579 (2013
10. Salah S, Watanabe K, Welter S, et al. Colorectal cancer pulmonary oligometastases: pooled analysis and construction of a clinical lung metastasectomy prognostic model. Ann. Oncol. 23(10), 2649-2655 (2012
11. Pfannschmidt J, Klode J, Muley T, Dienemann H, Hoffmann H. Nodal involvement at the time of pulmonary metastasectomy: experiences in 245 patients. Ann. Thorac. Surg. 81(2), 448-454 (2006
12. Hamaji M, Cassivi SD, Shen KR, et al. Is lymph node dissection required in pulmonary metastasectomy for colorectal adenocarcinoma?. Ann. Thorac. Surg. 94(6), 1796-1800 (2012
13. Renaud S, Alifano M, Falcoz PE, et al. Does nodal status influence survival?. Results of a 19-year systematic lymphadenectomy experience during lung metastasectomy of colorectal cancer. Interact. Cardiovasc. Thorac. Surg. 18(4), 482-487 (2014
14. S. Salah FA, Gonzalez M., Gervaz P., et al. Hamed: pulmonary metastasectomy in colorectal cancer patients with previously resected liver metastasis: pooled analysis. J. Clin. Oncol. doi:10.1245/s10434-014-4173- 9 (2014) (Epub ahead of print
15. Salah S, Watanabe K, Park JS, et al. Repeated resection of colorectal cancer pulmonary oligometastases: pooled analysis and prognostic assessment. Ann. Surg. Oncol. 20(6), 1955-1961 (2013